Back

Randomized controlled trial of intermittent fasting in Multiple Sclerosis

Official Title

Randomized controlled trial of intermittent fasting in Multiple Sclerosis

Study Details

The purpose of the study is to determine whether an intermittent fasting diet has beneficial effects in Multiple Sclerosis patients.

Principal Investigator

Dr. Laura Picco

IRB Number

201707010

Eligibility

1. Participants must be 18 or older with diagnosed with relapsing Multiple Sclerosis (MS)
2. Participants must have a body mass index (BMI) between 22 and 38
3. Participants must not have diabetes

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back